DOLETHAL 200 MG/ML SOLUTION FOR INJECTION
Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Summary of Product characteristics
(SPC)
29-08-2015
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
PENTOBARBITAL SODIUM
Available from:
Vetoquinol Ireland Limited
ATC code:
QN51AA01
INN (International Name):
PENTOBARBITAL SODIUM
Dosage:
200 Mg/Ml
Pharmaceutical form:
Solution for Injection
Prescription type:
VPO-Vet.Practitioner Only
Therapeutic group:
Canine, Feline
Therapeutic area:
Pentobarbital
Therapeutic indications:
Neurological Preparations
Authorization status:
Authorised
Authorization date:
1990-10-01
Summary of Product characteristics
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Dolethal 200 mg/ml Solution for Injection
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
3 PHARMACEUTICAL FORM
Solution for injection.
A red aqueous solution.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dogs, cats.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Euthanasia of dogs and cats.
4.3 CONTRAINDICATIONS
Not for anaesthetic use.
Not for use in animals intended for animal or human consumption.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
It may be necessary to increase the dose for older animals weighing more than 10 kg.
Each ml contains:
Active substance
Pentobarbital Sodium
200 mg
Excipients
Benzyl Alcohol
0.0104 ml
Cochineal Red A (E124)
0.01 mg
For a full list of excipients, see section 6.1
HEALTH PRODUCTS REGULATORY AUTHORITY
________________________________________________________________________________________________________________________
_Date Printed 14/08/2015_
_CRN 7021600_
_page number: 1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
None.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE MEDICINAL PRODUCT TO ANIMALS
Lethal to humans.
Particular care should be taken to avoid accidental exposure to the product.
In the case of accidental self-administration (injection, ingestion, skin absorption), seek URGENT medical attention,
advising medical services of barbiturate poisoning.
In the case of accidental contact with eyes, irrigate eyes immediately with flowing cold or tepid water.
In the case of contact with skin, wash immediately with water and then thoroughly with soap and water.
4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
None.
4.7 USE DURING PREGNANCY, LACTATION OR LAY
Not relevant.
4.8 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF INTERACTION
None.
4
Read the complete document
